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DeOBJECTIVES In this individual participant data meta-analysis on left ventricular global longitudinal strain (LVGLS), our
objective was to: 1) describe its distribution; 2) identify the most predictive cutoff values; and 3) assess its impact on
mortality in asymptomatic patients with significant aortic stenosis (AS) and preserved left ventricular ejection fraction
(LVEF).
BACKGROUND The evidence supporting the prognostic role of LVGLS in asymptomatic patients with AS has been
obtained from several relatively small studies.
METHODS A literature search was performed for studies published between 2005 and 2017 without language
restriction according to the following criteria: “aortic stenosis” AND “longitudinal strain.” The corresponding authors of
selected studies were contacted and invited to share their data that we computerized in a specific database. The primary
endpoint was all-cause mortality.
RESULTS Among the 10 studies included, 1,067 asymptomatic patients with significant AS and LVEF >50% were
analyzed. The median of LVGLS was 16.2% (from 5.6% to 30.1%). There were 91 deaths reported during follow-up with
median of 1.8 (0.9 to 2.8) years, resulting in a pooled crude mortality rate of 8.5%. The LVGLS performed well in the
prediction of death (area under the curve: 0.68). The best cutoff value identified was LVGLS of 14.7% (sensitivity, 60%;
specificity, 70%). Using random effects model, the risk of death for patients with LVGLS <14.7% is multiplied by
>2.5 (hazard ratio: 2.62; 95% confidence interval: 1.66 to 4.13; p < 0.0001), without significant heterogeneity between
studies (I2 ¼ 18.3%; p ¼ 0.275). The relationship between LVGLS and mortality remained significant in patients with
LVEF $60% (p ¼ 0.001).
CONCLUSIONS This individual participant data meta-analysis demonstrates that in asymptomatic patients with
significant AS and normal LVEF, impaired LVGLS is associated with reduced survival. These data emphasize the potential
usefulness of LVGLS for risk stratification and management of these patients. (J Am Coll Cardiol Img 2019;12:84–92)
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85AB BR E V I A T I O N S
AND ACRONYM S
AS = aortic stenosis
AVAi = indexed aortic valve
area
CI = confidence interval
GLS = global longitudinal
strain
HR = hazard ratio
LV = left ventricular
LVEF = left ventricular
ejection fractionT he assessment of left ventricular (LV) func-tion using LV ejection fraction (LVEF) has acentral place in the current guidelines for
the management of patients with severe aortic steno-
sis (AS), particularly when still asymptomatic. The
current American Heart Association/American Col-
lege of Cardiology and European Society of Cardiol-
ogy guidelines recommend as Class I indication
(Level of Evidence: B) to perform aortic valve inter-
vention in asymptomatic patients when LVEF
becomes <50% (1,2). However, these concomitant
findings are rare (3) and symptoms generally occur
well before decrease in LVEF, which, in turn, remains
preserved for long in patients with AS. Several recent
studies demonstrate, using cardiac magnetic reso-
nance, that LV structural and functional abnormal-
ities may be frequent despite LVEF >50% (4–9). This
may partially explain the reduced post-operative sur-
vival of patients with LVEF 50% to 60% (3,10).
Furthermore, aortic valve intervention in patients
with LVEF <50% frequently results in suboptimal
post-operative LV function recovery, contributing to
persistent symptoms, limited functional capacity
and quality of life, and increased risk of events.
Consequently, this underlines the need to identify
echocardiographic parameters better than LVEF to
more accurately assess the consequences of AS-
related LV pressure overload on LV function.SEE PAGE 93The impairment of LV longitudinal shortening is
associated with myocardial fibrosis (11,12), which is,
in turn, a potential prognostic marker in patients with
AS (6,13). Hence, LV longitudinal function assess-
ment, using speckle-tracking echocardiography, may
provide a surrogate imaging marker of myocardial
damage. Indeed, there is growing evidence suggest-
ing the potential prognostic role of LV myocardial
longitudinal function, as assessed by global longitu-
dinal strain (GLS), in asymptomatic patients with AS.
However, the available data are mainly derived from
relatively small series and/or from single-center
studies. In addition, current series report various
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Manuscript received July 12, 2018; revised manuscript received November 9Our objective was therefore to perform an
individual participant data meta-analysis to:
1) describe the distribution; 2) identify the
most predictive cutoff values; and 3) assess
the impact of LVGLS on mortality in asymp-
tomatic patients with significant AS and pre-
served LVEF.
METHODS
We searched MEDLINE, Embase, and the
Cochrane Library database using the key
terms “aortic valve stenosis” and “longitudi-
nal strain” between 2005 and 2017 without language
restriction. The protocol of this individual participant
data meta-analysis was validated by the Research &
Innovation Committee of the European Association of
Cardiovascular Imaging and the study was conducted
on behalf of all members of the Committee. The
PRISMA statement (14) was followed to conduct the
individual participant data meta-analysis.
INCLUSION CRITERIA. Studies were selected for the
meta-analysis if they included patients with all of the
following criteria: 1) asymptomatic; 2) preserved
LVEF (i.e., >50%); 3) greater than or equal to mod-
erate AS, as defined by current guidelines at the time
of the study; 4) quantification of the LVGLS using 2-
dimensional speckle tracking; and 5) availability of
outcome of interest for the current analysis (i.e., all-
cause death). No inclusion criterion was applied
regarding sample size.
SELECTION OF STUDIES. A first selection of the
studies was based on the title and on the abstract. The
full articles of all selected studies were then con-
sulted to verify all pre-specified inclusion criteria.
The selection of the studies was performed simulta-
neously during specific meeting (J.M., B.C., and E.D.).
The flow chart illustrating the selection of the studies
process is reported in Figure 1. Great care was taken
to avoid inclusion of various studies based on the
same cohort population to avoid redundancy in the
meta-analysis.
Finally, all corresponding authors and/or first,
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FIGURE 1 Flow Chart
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Selection and inclusion of the studies.
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86by email to propose them to participate in the
meta-analysis. Responding authors were invited to
share a short, anonymized database including a
limited number of variables. The required variables
were age, gender, comorbidities (coronary artery
disease, hypertension, diabetes, dyslipidemia), AS
severity, LVEF, LVGLS, and outcome data. The data
were then computerized in a dedicated database.
PRIMARY ENDPOINT. The primary endpoint of this
individual participant data meta-analysis was
all-cause death. Purposely, combined endpoint
including need for aortic valve intervention was not
used in the meta-analysis. This is justified by the
fact that the decision-making regarding indication
for intervention may considerably vary between
centers.
STATISTICAL ANALYSIS. Extraneous data were
removed from the database and units of continuous
variables were standardized and continuous variables
were dichotomized.
Descriptive analysis was performed and mean  SD
or proportion was reported. The distribution ofLVGLS was compared according to each included
study using 1-way analysis of variance.
A univariate Cox proportional hazards model was
used to derive, for each study, the hazard ratio (HR),
standard error, and 95% confidence interval (CI)
related to LVGLS (as continuous variables) and
occurrence of death. Log transformation was per-
formed and inverse variances as weights were then
calculated for each study. The meta-analysis was
performed using random effects models and forest
plots were generated to express the pooled effect.
Heterogeneity was assessed using I2. Stratified anal-
ysis was performed according to LVEF with a pre-
specified arbitrary cutoff value of 60%.
To assess the potential impact of vendor difference
on the results, a stratified analysis was performed
according to vendor. The best cutoff value of LVGLS
associated with death was derived from receiver
operating characteristic curve analysis and selected
using the best compromise between sensitivity and
specificity and the Youden index. This cutoff was
then used to generate Kaplan-Meier analysis and to
assess the impact of LVGLS on death in multivariate
Cox proportional hazards model.
To assess the incremental prognostic value of
LVGLS over LVEF, we calculated integrated discrim-
ination improvement as recommended (15).
To simplify the interpretation and discussion of the
results, although negative, LVGLS is reported
as positive values. All statistical analyses were per-
formed using SPSS version 23 (IBM, Armonk, New
York) and STATA version 13 (StataCorp LP, College
Station, Texas).
RESULTS
A total of 10 studies, including 1,067 asymptomatic
patients with LVEF >50%, were used for the present
individual participant data meta-analysis. The data-
set was completed for LVGLS and outcome data.
There was 0.8% of missing values for LVEF (i.e., pa-
tients with LVEF >50% but without exact value). The
selected studies are summarized in Table 1, and the
description of the population is reported in Table 2.
The median LVGLS was 16.2% (from 5.6% to
30.1%). A LVGLS >13.7% was observed in 75% of pa-
tients and <15% of patients had LVGLS >20% (i.e.,
preserved LV longitudinal function). In patients with
severe AS (i.e., indexed aortic valve area [AVAi] <0.6
cm2/m2), the median LVGLS was 16.3% (from 6% to
30.1%).
The distribution of LVGLS according to selected
studies is reported in Figure 2. Although the study
TABLE 1 Description of Selected Studies




(cm2/m2) Vendor LVGLS Cutoff Outcome
Lancellotti et al. (32) 2010 Prospective/bicentric 163 0.45  0.09 GE 15.9% MACE
Zito et al. (33) 2011 Prospective/monocentric 82 0.40  0.10 GE 18% MACE
Dahl et al. (18) 2012 Prospective/monocentric 65 0.46  0.19 GE Quartile MACE
Kearney et al. (34) 2012 Prospective/monocentric 77 0.56  0.23 GE 15% All-cause death
Yingchoncharoen et al. (17) 2012 Prospective/monocentric 78 0.39  0.13 Siemens 15% MACE
Kusunose et al. (35) 2014 Retrospective/monocentric 137 0.42  0.2 Siemens Quartile All-cause death
Sato et al. (16) 2014 Retrospective/multicentric 142 0.42  0.11 GE 17% MACE
Carstensen et al. (36) 2015 Prospective/multicentric 104 0.49  0.13 GE 15% MACE
Nagata et al. (37) 2015 Prospective/multicentric 102 0.42  0.10 TomTec 17% MACE
Salaun et al. (38) 2017 Prospective/multicentric 117 0.47  0.11 GE Tertile All-cause death
AVAi ¼ indexed aortic valve area; GE ¼ General Electric; LVGLS ¼ left ventricular global longitudinal strain; MACE ¼ major adverse cardiac event.
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87from Sato et al. (16) reported significantly higher
values and the study of Yingchoncharoen et al. (17)
significantly lower values (p < 0.0001), there was a
good homogeneity between studies regarding LVGLS
values (Figure 2). In studies using equipment only
from the most commonly used vendor (GE Health-
care, Horten, Norway), the median LVGLS was 16.6%
(from 6% to 30.1%).
LVGLS AND MORTALITY. Among the 10 selected
studies, 91 deaths were reported during a median
follow-up of 1.8 years, from 0 to 8.5 years, resulting
in a pooled crude rate of death of 8.5% (range,
2.8% to 18.5%). In patients with LVEF $60% (n ¼ 734),
61 deaths occurred (8.3%; range, 3.0% to 17.3%).
In the whole cohort, LVGLS was well associated
with occurrence of death (area under the curve: 0.68).
The best cutoff value identified was LVGLS of 14.7%
(sensitivity, 60%; specificity, 70%). By comparison,
LVEF depicted lesser association with occurrence ofTABLE 2 Population Characteristics (N ¼ 1,067)
Age, yrs 74  10
Body surface area, m2 1.79  0.26
Male, % 56
Comorbidities, %





Indexed aortic valve area, cm2/m2 0.49  0.17
Severe AS,* % 82
LVEF, % 63.5  8
LVEF >60%, % 65
LV global longitudinal strain, % 16.2  3.6
Values are mean  SD or %. *Severe AS is defined as an indexed aortic valve
area <0.6 cm2/m2.
AS ¼ aortic stenosis; EF ¼ ejection fraction; LV ¼ left ventricular.death (area under the curve: 0.56). In patients with
severe AS (i.e., AVA <0.6 cm2/m2), area under the
curve for LVGLS was 0.69.
The relationship between LVGLS and risk of death
is assessed using spline function. The spline curve
suggests a marked increase risk of mortality when
LVGLS decrease below 15% (Supplemental Figure 1).
In studies performed with the GE machine, the
predictive value of LVGLS was similar (area under the
curve: 0.69) and the best cutoff value was 14.7%
(sensitivity, 62%; specificity, 74%). The predictive
value in studies without GE machine was lower (area
under the curve: 0.62) and the best cutoff value was
11.9% with markedly lower sensitivity (35%) but
higher specificity (86%).
In the whole cohort, impaired LVGLS <14.7% was
found in 32.3% of patients, with significant difference
between the studies (from 15.5% to 56%; p < 0.0001).
Applying this cutoff value to all selected studies
allowed to generate a forest plot (Figure 3A) showing
that the risk of death for patients with LVGLS <14.7%
was multiplied by >2.5 (HR: 2.62; 95% CI: 1.66 to 4.13;
p < 0.0001), without significant heterogeneity
(I2 ¼ 18.3%; p ¼ 0.275). The relationship between
LVGLS <14.7% and mortality was also significant in
patients with LVEF $60% (Figure 3B). With a strati-
fication according to vendor (i.e., GE vs. others)
(Supplemental Figure 2), similar results were found.
Because all patients from the Dahl et al. (18) study
were referred for surgery, we performed a subanalysis
excluding this study. Similar results than in the whole
cohort were found (HR: 2.25; 95% CI: 1.47 to 3.43; p <
0.0001; I 2 ¼ 8.0%, p ¼ 0.369).
In patients with severe AS (i.e., AVAi <0.6 cm2/m2),
forest plot showed that the risk of death in patients
with LVGLS <14.7% was higher than in the whole
cohort (HR: 3.58; 95% CI: 1.84 to 6.99; p < 0.0001;
I2 ¼ 0, p < 0.0001).




























































































Circles indicate outliers. LV ¼ left ventricular.
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88Using the cutoff of 14.7%, impaired LVGLS was
associated with markedly reduced survival both in
the whole cohort (p < 0.0001) (Figure 4A) and in pa-
tients with LVEF $60% (p < 0.0001) (Figure 4B). Pa-
tients with LVGLS >18% have similar survival (at 2
years, 97  1%) than those with LVGLS between 16.2%
and 18% (at 2 years: 95  2%; p ¼ 0.445) or even those
with LVGLS between 14.7% and 16.2% (at 2 years 95 
2%; p ¼ 0.207).
In patients with severe AS (i.e., AVAi <0.6 cm2/m2),
2-year survival was significantly lower in patients
with impaired LVGLS than in those with preserved
LVGLS (81  4% vs. 94  1%; p < 0.0001) (Supple-
mental Figure 3).
In multivariate analysis, after adjustment for age,
gender, AVAi, and LVEF, impaired LVGLS
(i.e., <14.7%) was a strong independent determinant
of mortality (HR: 3.59; 95% CI: 2.16 to 5.98; p <
0.0001).
Adding impaired LVGLS to the multivariate model
(i.e., including age, gender, AVAi, and LVEF) mark-
edly improve its prediction (from chi square of 13.1 to
chi square of 40.5). Comparing with LVEF, integrated
discrimination improvement was positive for
both LVGLS (i.e., as continuous variable) and
LVGLS <14.7% suggesting its incremental prognostic
value over LVEF (0.028 and 0.026, respectively).
PUBLICATION BIAS ASSESSMENT. Funnel plots,
regarding impaired LVGLS and risk of death
(Supplemental Figure 4), demonstrated significantasymmetry (Egger test; p ¼ 0.01) suggesting potential
presence of publication bias. Funnel plots analysis
demonstrates that this asymmetry may be related to
discrepancy in publication in favor of studies report-
ing large effect size despite small sample size or large
variance. In contrast, Begg test demonstrated no
significant risk of publication bias (p ¼ 0.18).
DISCUSSION
In asymptomatic patients with significant AS and
preserved LVEF, the present individual participant
data meta-analysis suggests that: 1) LVGLS is rela-
tively homogeneous across available published
cohorts; 2) LVGLS better than 20% is rare in this
population; and 3) LVGLS is strongly associated with
mortality, with >2.5-fold increase in risk of death in
patients with impaired LVGLS. Of interest, the close
independent relationship between LVGLS and mor-
tality is sustained even when LVEF is $60%. A cutoff
value of 14.7% seems to be associated with patients at
a higher risk of death.
LV LONGITUDINAL FUNCTION AND MYOCARDIAL
FIBROSIS. The alteration of LV longitudinal function
occurs in parallel to AS severity (19), LV morphologic
changes (20), LV myocardial damage, and fibrosis
proliferation (11). Weidemann et al. (11) reported that
the severity of myocardial fibrosis estimated with
histologic analysis was associated with impairment of
LV longitudinal shortening as assessed by mitral
annulus displacement using M-mode echocardiogra-
phy. In addition, the presence of LV myocardial
fibrosis may predict the risk of lack of LV function
recovery following aortic valve replacement (13) and
outcome (6). Based on these studies, it seems that the
development of LV fibrosis is the main pathophysio-
logic mechanism involved in the reduction in LV
longitudinal shortening in patients with AS. Never-
theless, these findings were obtained in patients with
surgical indications or with markedly reduced LVEF,
limiting the clinical usefulness of LV longitudinal
function assessment in these cohorts. Indeed, the LV
longitudinal function evaluation could be more rele-
vant to detect subclinical LV dysfunction and manage
asymptomatic patients with preserved LVEF.
The presence of transthyretin cardiac amyloidosis
(21), which in patients with AS is frequently associ-
ated with impaired longitudinal LV shortening
without apical sparing, could also partially explain
the reduction in LVGLS.
LVGLS DERIVED FROM SPECKLE TRACKING ECHO-
CARDIOGRAPHY. Speckle tracking echocardiography
is a non-Doppler modality, angle-independent,
allowing measurement of myocardial deformation
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Overall effect test: z = 3.44, p = O.001
Overall (I2 = 0.0%, p = 0.737)
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Forest plot reporting the pooled effect of impaired left ventricular global longitudinal strain (i.e., <14.7%) on mortality in the whole cohort
(A) and in patients with left ventricular ejection fraction $60% (B). CI ¼ confidence interval; HR ¼ hazard ratio.
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89(22). The quantification of LVGLS is now the most
common application of speckle tracking echocardi-
ography and has already demonstrated added diag-
nostic and prognostic value in a wide range of
conditions including valvular heart disease (23).
Moreover, LVGLS during exercise may identify LVdysfunction associated with the development of
symptoms (24).
Derived from 2-, 3-, and 4-chamber apical views,
LVGLS can be easily calculated with good feasibility
and both interobserver and intraobserver reproduc-
ibility (25,26), even better than LVEF. The relative
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Kaplan-Meier survival curves stratified according to left ventricular global longitudinal strain in the whole cohort (A) and in patients with left
ventricular ejection fraction $60% (B). Percentage in the graphs are survival rate at 2- and 4-year follow-up. LVGLS ¼ left ventricular global
longitudinal strain.
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90interobserver and intraobserver variability of GLS
approximately varies from 5% to 8% according to
vendors. By contrast, 8% and 10% of variability are
reported for LVEF, respectively (25). Nevertheless,
LVGLS remains load and geometry dependent and
needs to be carefully interpreted in many cases.
LVGLS AND LVEF. The obvious advantages of LVGLS
over LVEF are its ability to unmask subclinical LV
dysfunction, to identify early structural and
morphologic myocardial damage, and to better pre-
dict post-operative LV dysfunction and outcome (27).
Many cardiac magnetic resonance studies recently
reported myocardial alterations, despite preserved
LVEF. The presence of LV late gadolinium enhance-
ment has been highlighted in patients with various
degrees of AS, despite normal LVEF (4–6). A graded
relationship between AS severity and longer T1 time,
regardless of LVEF (assessed using cardiac magnetic
resonance), has been shown (5,7) and there have been
good correlations between native T1 values and
collagen volume fraction obtained by myocardial bi-
opsies (7,28). Of interest, a large proportion of pa-
tients with AS and with high presence of LV late
gadolinium enhancement or with markedly elevated
T1 values still have preserved LV ejection. Further-
more, LVEF does not follow AS severity whereas
LVGLS has been found to gradually worsen when AS
becomes more severe (19). Altogether, these recent
data highlight the superiority of LVGLS over LVEF toassess LV myocardial function and predict outcomes
of asymptomatic patients with AS.
CLINICAL IMPLICATIONS. The present individual
participant data meta-analysis shows, in a large cohort
of patients, that LVGLS may have a close association
with survival and could suggest a better risk stratifi-
cation value than LVEF. However, the existing evi-
dence has often considered aortic valve intervention
in a composite endpoint, with the consequence that
intervention influenced event-free survival. In the
present study, LVGLS demonstrated its strong impact
on mortality and, therefore, the crucial role that it may
have in the risk stratification and management of pa-
tients with asymptomatic AS. The close relationship
between death and impaired LVGLS suggests that this
echocardiographic parameter could be implemented
in future guideline recommendations, if the present
results are confirmed by large multicenter studies.
Indeed, a heart team discussion of early intervention
(i.e., including transcatheter aortic valve replacement
if necessary) in asymptomatic patients with preserved
LVEF but impaired LVGLS <14.7% may be envisaged.
Further confirmation about the need for intervention,
related to myocardial morphologic and structural
damage, may be obtained by performing cardiac
magnetic resonance and assessment of the presence of
late gadolinium enhancement and/or quantification of
native T1. Furthermore, the use of exercise stress
echocardiography in these patients may also be
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The prognostic
value of LVGLS in patients with AS often arises from small, single-
center studies, including heterogeneous grade and stage of AS.
Impaired LVGLS (i.e., <14.7%) is strongly associated with mor-
tality in asymptomatic patients with significant AS. This is
confirmed in patients with severe AS (i.e., indexed aortic valve
area <0.6 cm2/m2) and in patients with LVEF >60%. This indi-
vidual participant data meta-analysis confirmed the usefulness of
LVGLS in the management and risk stratification of these patients
and may have incremental value as compared with the LVEF.
TRANSLATIONAL OUTLOOK: The effort to improve repro-
ducibility of LVGLS measurement between vendors should be
sustained. Large multicenter prospective study aiming to confirm
our results is now mandatory. The usefulness of LVGLS, as
trigger for surgery, should also be tested in experimental trial,
more particularly to test its benefit as compared with LVEF.
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91discussed (29,30). Patients with good LVGLS>18% had
an excellent outcome (i.e., 97  1% 2-year survival)
supporting a conservative approach with clinical and
echocardiographic assessment every 1 to 2 years, in the
absence of other indications for intervention or ab-
normality during exercise stress echocardiography.
Our results show that the survival of patients with
depressed LVGLS between 14.7% and 18% is similar to
thosewith preserved LVGLS>18%up to 2 years follow-
up. With worse LVGLS values beyond 14.7% a marked
increase in mortality seems to occur. This may rather
promote shorter follow-up intervals (every 6 to 12
months), to assess subtle changes in LVGLS and/or
symptoms and to propose prompt intervention.
STUDY LIMITATIONS. This study holds similar limi-
tations to all meta-analyses. However, the use of in-
dividual data rather than data derived from
publication only may substantially improve the
robustness of the reported results. Furthermore, the
low degree of heterogeneity found indicates a relative
consensus in the published data.
Although uncommon in asymptomatic patients
with preserved LVEF, we cannot exclude the presence
of low flow/low gradient AS in the present cohort.
The lack of subanalysis according to brain natri-
uretic peptide may limit our conclusion. However,
this biomarker was not available in all selected
studies and were not incorporated into guidelines
when they were published.
The Egger and Begg tests produced discrepant re-
sults. However, analysis of the funnel plot suggests
an asymmetry between studies’ effect sizes and,
therefore, a limited but potential publication bias.
This is to be expected because positive studies may
generally have higher chance to be published than
negative ones. However, the studies selected in the
present meta-analysis were positive on the basis of
combined endpoints, including aortic valve inter-
vention. Of note, half of studies selected were nega-
tive with regards to all-cause mortality, further
limiting the potential publication bias.
We report all-cause mortality because it is more
objective, especially in retrospective studies. Car-
diovascular death is difficult to assess in retrospective
studies (31) and was not available in all publications.
The need to perform aortic valve intervention with
class I indication as recommended in current guide-
lines is a frequent endpoint in patients with AS.
However, the variety of centers and countries
involved in the meta-analysis does not allow suffi-
cient standardization to assess this endpoint.
Exercise testing aimed at confirming the asymp-
tomatic status of patients was not systematically
performed in all selected studies. Some apparentlyasymptomatic patients have abnormalities during
exercise testing, and these may have been included in
the meta-analysis.
Most studies included in the meta-analysis per-
formed LVGLS measurement using a GE machine.
Consequently, the present results could not be auto-
matically transposed to all echocardiographs. How-
ever, LVGLS is known to have good reproducibility,
limited difference between vendors, and to be supe-
rior to conventional echocardiographic measure-
ments (25).
CONCLUSIONS
This individual participant data meta-analysis dem-
onstrates the strong relationship between LVGLS and
all-cause mortality in asymptomatic patients with AS
and preserved LVEF. These results support the sys-
tematic measurement of LVGLS for the risk stratifi-
cation and the management of these patients and
may promote its use in clinical practice as an impor-
tant additive parameter for decision-making. A
LVGLS <14.7% could be considered as a trigger for
further imaging investigations and for early inter-
vention. Nonetheless, a limited but potential risk of
publication bias may be present in current literature,
suggesting the value of a large prospective interna-
tional study for confirming this key impact of GLS for
our patients with AS.
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